Back to Journals » ClinicoEconomics and Outcomes Research » Volume 10
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Cost-effectiveness comparison of cabozantinib with everolimus, axitinib, and nivolumab in the treatment of advanced renal cell carcinoma following the failure of prior therapy in England
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
12,959 | Dovepress* | 10,206+ | 1,713 | 11,919 | |
PubMed Central* | 2,753 | 519 | 3,272 | ||
Totals | 12,959 | 2,232 | 15,191 | ||
*Since 23 April 2018 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
4 | 0 | 0 | 0 | 2 | 2 |
View citations on PubMed and Google Scholar